Overview Recent surveillance data from Cambodia reveal a concerning resurgence of zoonotic human infections with highly pathogenic avian influenza (HPAI) H5N1 after more than a decade of apparent absence. Between...
As presented in a recent Vaccelerate webinar, researchers at the University Hospital Cologne represent a major advancement in population-based infectious disease surveillance. Conducted over 12 months and sponsored by...
Mumps virus infection can impair fertility in both sexes, though permanent sterility occurs far less frequently than transient testicular or ovarian inflammation. In post-pubertal males, mumps orchitis remains the most...
Background Post-acute sequelae of SARS-CoV-2 infection (PASC), commonly termed “long COVID,” continue to impose significant burdens on affected individuals and healthcare systems. While previous studies have clarified...
October 18 2025 – Pfizer Inc. reported strong global engagement ahead of IDWeek 2025 in Atlanta, where the company presented findings from 46 clinical and real-world vaccine studies covering COVID-19, RSV, pneumococcal...
According to the WHO Global Vaccine Market Report 2024 and supporting financial data from major pharmaceutical rankings and peer-reviewed analyses, the following twelve companies accounted for the most global human...
Rift Valley fever (RVF) is a mosquito-borne viral zoonosis that affects humans and livestock, primarily in Africa, with occasional outbreaks in the Middle East. The following summarizes current knowledge on clinical...
Recent rubella epidemiology, including congenital rubella syndrome (CRS), shows global disparities and recurring outbreaks in areas of suboptimal vaccine coverage. Surveillance data through October 2025 highlight...
Epidemiologic overview (2025) As of October 7, 2025, a total of 1,563 confirmed measles cases have been reported in the United States, spanning 42 jurisdictions, including major metropolitan areas such as New York City...